Capital Investment Advisory Services’s ProShares Ultra Health Care RXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $71.3K | Buy |
1,756
+5
| +0.3% | +$203 | 0.01% | 698 |
|
|
2025
Q1 | $85K | Sell |
1,751
-500
| -22% | -$24.3K | 0.01% | 639 |
|
|
2024
Q4 | $99K | Buy |
2,251
+11
| +0.5% | +$484 | 0.01% | 570 |
|
|
2024
Q3 | $125K | Buy |
2,240
+8
| +0.4% | +$447 | 0.01% | 559 |
|
|
2024
Q2 | $114K | Hold |
2,232
| – | – | 0.01% | 551 |
|
|
2024
Q1 | $119K | Buy |
2,232
+4
| +0.2% | +$212 | 0.01% | 541 |
|
|
2023
Q4 | $102K | Buy |
2,228
+4
| +0.2% | +$183 | 0.01% | 564 |
|
|
2023
Q3 | $91.9K | Sell |
2,224
-1,228
| -36% | -$50.7K | 0.01% | 545 |
|
|
2023
Q2 | $154K | Hold |
3,452
| – | – | 0.02% | 493 |
|
|
2023
Q1 | $148K | Buy |
3,452
+8
| +0.2% | +$342 | 0.02% | 496 |
|
|
2022
Q4 | $163K | Buy |
+3,444
| New | +$163K | 0.02% | 489 |
|